Aegon N.V.

AGN.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AGN.AS stands at 10B. In comparison, CS.PA has a market cap of 92.5B. Regarding current trading prices, AGN.AS is priced at €6.29, while CS.PA trades at €42.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AGN.AS currently has a P/E ratio of 16.99, whereas CS.PA's P/E ratio is 13.12. In terms of profitability, AGN.AS's ROE is +0.08%, compared to CS.PA's ROE of +0.17%. Regarding short-term risk, AGN.AS is less volatile compared to CS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AGN.AS.

AGN.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AGN.AS stands at 10B. In comparison, GEN.BR has a market cap of 30.7B. Regarding current trading prices, AGN.AS is priced at €6.29, while GEN.BR trades at €19.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AGN.AS currently has a P/E ratio of 16.99, whereas GEN.BR's P/E ratio is 7.30. In terms of profitability, AGN.AS's ROE is +0.08%, compared to GEN.BR's ROE of +0.18%. Regarding short-term risk, AGN.AS is more volatile compared to GEN.BR. This indicates potentially higher risk in terms of short-term price fluctuations for AGN.AS.

AGN.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AGN.AS stands at 10B. In comparison, NN.AS has a market cap of 15.3B. Regarding current trading prices, AGN.AS is priced at €6.29, while NN.AS trades at €57.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AGN.AS currently has a P/E ratio of 16.99, whereas NN.AS's P/E ratio is 10.23. In terms of profitability, AGN.AS's ROE is +0.08%, compared to NN.AS's ROE of +0.07%. Regarding short-term risk, AGN.AS is less volatile compared to NN.AS. This indicates potentially lower risk in terms of short-term price fluctuations for AGN.AS.

AGN.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AGN.AS stands at 10B. In comparison, ASRNL.AS has a market cap of 11.8B. Regarding current trading prices, AGN.AS is priced at €6.29, while ASRNL.AS trades at €56.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AGN.AS currently has a P/E ratio of 16.99, whereas ASRNL.AS's P/E ratio is 12.82. In terms of profitability, AGN.AS's ROE is +0.08%, compared to ASRNL.AS's ROE of +0.09%. Regarding short-term risk, AGN.AS is less volatile compared to ASRNL.AS. This indicates potentially lower risk in terms of short-term price fluctuations for AGN.AS.

AGN.AS plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AGN.AS stands at 10B. In comparison, AGS.BR has a market cap of 10.9B. Regarding current trading prices, AGN.AS is priced at €6.29, while AGS.BR trades at €56.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AGN.AS currently has a P/E ratio of 16.99, whereas AGS.BR's P/E ratio is 9.28. In terms of profitability, AGN.AS's ROE is +0.08%, compared to AGS.BR's ROE of +0.11%. Regarding short-term risk, AGN.AS is more volatile compared to AGS.BR. This indicates potentially higher risk in terms of short-term price fluctuations for AGN.AS.